Dynavax Technologies Corporation (LON:0IDA)
London · Delayed Price · Currency is GBP · Price in USD 15.49
-0.01 (-0.03%)
Feb 9, 2026, 5:37 PM GMT
Dynavax Technologies Market Cap
The market cap or net worth for Dynavax Technologies is currently unavailable.
Market Cap
n/a
Enterprise Value
n/a
Revenue
245.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.49
Market Cap Chart
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 1.29B | -0.77% |
| Dec 31, 2025 | 1.30B | -3.12% |
| Dec 31, 2024 | 1.34B | -5.49% |
| Dec 29, 2023 | 1.42B | 25.92% |
| Dec 30, 2022 | 1.13B | -9.61% |
| Dec 31, 2021 | 1.25B | 247.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 218.75B |
| GSK plc | 86.64B |
| Haleon | 34.95B |
| Smith & Nephew | 10.82B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.82B |
| Oxford Nanopore Technologies | 1.36B |
| Oxford Biomedica | 977.54M |